Ioannis Mantzaris

3.1k total citations · 1 hit paper
70 papers, 812 citations indexed

About

Ioannis Mantzaris is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Ioannis Mantzaris has authored 70 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 23 papers in Oncology and 14 papers in Genetics. Recurrent topics in Ioannis Mantzaris's work include Acute Myeloid Leukemia Research (24 papers), Acute Lymphoblastic Leukemia research (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). Ioannis Mantzaris is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Acute Lymphoblastic Leukemia research (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). Ioannis Mantzaris collaborates with scholars based in United States, Greece and United Kingdom. Ioannis Mantzaris's co-authors include Amit Verma, Marie Christiane Vekemans, Stephen Booth, Fernando Martín‐Moro, Inna Y. Gong, Thomas A. Fox, Thomas Chatzikonstantinou, Bruno Fattizzo, Abi Vijenthira and John C. Riches and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Ioannis Mantzaris

49 papers receiving 804 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

2020 330 citations Ioannis Mantzaris et al. Blood profile →

Peers

Ioannis Mantzaris

ONCOL

HEMAT

IMMUN

Fabrice Monpoux France

Yukiko Kishi Japan

Monzr M. Al Malki United States

Aki Chizuka Japan

Moussab Damlaj Saudi Arabia

Mathew Simcock Switzerland

Anders Tveita Norway

J.A. Gastaut France

Saiko Kurosawa Japan

Richard Champlin United States

Fabrice Monpoux France

Ioannis Mantzaris

214 ×0.6

ONCOL

311 ×1.3

311 ×1.7

HEMAT

133 ×0.9

IMMUN

179 ×1.3

Citations per year, relative to Ioannis Mantzaris Ioannis Mantzaris (= 1×) peers Fabrice Monpoux

Countries citing papers authored by Ioannis Mantzaris

Since Specialization

Citations

This map shows the geographic impact of Ioannis Mantzaris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioannis Mantzaris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioannis Mantzaris more than expected).

Fields of papers citing papers by Ioannis Mantzaris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioannis Mantzaris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioannis Mantzaris. The network helps show where Ioannis Mantzaris may publish in the future.

Co-authorship network of co-authors of Ioannis Mantzaris

This figure shows the co-authorship network connecting the top 25 collaborators of Ioannis Mantzaris. A scholar is included among the top collaborators of Ioannis Mantzaris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioannis Mantzaris. Ioannis Mantzaris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hammami, M Bakri, Mendel Goldfinger, Nishi Shah, et al.. (2024). Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort. Transplantation and Cellular Therapy. 30(5). 544.e1–544.e8. 3 indexed citations

Yan, John, M Bakri Hammami, Nishi Shah, et al.. (2024). Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database. Annals of Hematology. 103(9). 3543–3551.

Sapna, Fnu, et al.. (2024). Case report: Isolated oligometastatic disease of the prostate from a primary lung adenocarcinoma. Frontiers in Oncology. 14. 1394168–1394168.

Levitz, David, Yogen Saunthararajah, Lauren Shapiro, et al.. (2023). A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML. Clinical Cancer Research. 29(15). 2774–2780. 10 indexed citations

Sisto, Alex, David Levitz, Ioannis Mantzaris, et al.. (2023). Transportation Cost Is a Significant Barrier to Quality Care for Hematologic Malignancy Patients in a Minority-Rich, Socioeconomically Disadvantaged Population. Blood. 142(Supplement 1). 2350–2350. 1 indexed citations

Konopleva, Marina, Vijaya Raj Bhatt, Ioannis Mantzaris, et al.. (2023). A Phase I, Single-Arm, Open Label, Dose Escalation, Multicenter Study of Off-the-Shelf Natural Killer (NK) Cells (SAR445419) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (R/R AML). Blood. 142(Supplement 1). 5972–5972.

Davis, Timothy M. E., Lauren Shapiro, Aditi Shastri, et al.. (2023). High Dose Cyclophosphamide for the Treatment of Severe Immune Checkpoint Inhibitor Related Adverse Events. PubMed. 8(4).

Sisto, Alex, David Levitz, Ioannis Mantzaris, et al.. (2023). A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx. Blood. 142(Supplement 1). 7397–7397.

Shapiro, Lauren M., Ioannis Mantzaris, Aditi Shastri, et al.. (2022). AML-351 Low-Dose Weekly Decitabine and Venetoclax in Myeloid Malignancies. Clinical Lymphoma Myeloma & Leukemia. 22. S241–S241.

10.

Shah, Nishi, Jiahao Chen, Karen Fehn, et al.. (2021). Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML. Experimental Hematology and Oncology. 10(1). 1–1. 9 indexed citations

11.

Mantzaris, Ioannis, et al.. (2020). Influence of Rurality, Race, and Ethnicity on Non-Hodgkin Lymphoma Incidence. Clinical Lymphoma Myeloma & Leukemia. 20(10). 668–676.e5. 12 indexed citations

12.

Gali, Radhika, et al.. (2020). Late-Onset Cytokine Release Syndrome (CRS) in HIV Patient with Relapsed Classical Hodgkin Lymphoma on Nivolumab and Non-Compliance with Anti-Retroviral Therapy. Blood. 136(Supplement 1). 17–17.

13.

Gluck, Caroline, Chengxiang Qiu, Sang Youb Han, et al.. (2019). Kidney cytosine methylation changes improve renal function decline estimation in patients with diabetic kidney disease. Nature Communications. 10(1). 2461–2461. 59 indexed citations

14.

Herrera, Diego Adrianzen, Noah Kornblum, Ana Acuña-Villaorduña, et al.. (2019). Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1–Associated Adult T Cell Lymphoma–Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center. Biology of Blood and Marrow Transplantation. 25(6). e199–e203. 6 indexed citations

15.

Kam, Audrey E., Gopichand Pendurti, Umang Shah, et al.. (2018). Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trials. Investigational New Drugs. 37(3). 490–497. 6 indexed citations

16.

Gonzalez‐Lugo, Jesus D., Rafi Kabarriti, & Ioannis Mantzaris. (2018). Osteoradionecrosis of the jaw in a patient with lymphoma treated with rituximab and concomitant involved field radiation therapy. Advances in Radiation Oncology. 3(4). 701–704.

17.

Shah, Urvi A., Beamon Agarwal, Aditi Shastri, et al.. (2018). Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure. Case Reports in Oncological Medicine. 2018. 1–6.

18.

Thibaud, Santiago, Diego Adrianzen Herrera, Ioannis Mantzaris, et al.. (2017). Obesity Is Associated with Younger Age at Presentation and More Severe Cytopenias in Myelodysplastic Syndromes. Blood. 130. 5312. 1 indexed citations

19.

Msaouel, Pavlos, Anna Lam, Krishna Gundabolu, et al.. (2014). Abnormal platelet count is an independent predictor of mortality in the elderly and is influenced by ethnicity. Haematologica. 99(5). 930–936. 49 indexed citations

20.

Kountourakis, Panteleimon, et al.. (2008). Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer. Journal of Clinical Oncology. 26(15_suppl). 15085–15085. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact